{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-24-001003","form_type":"8-K","ticker":"AVXL","cik":"0001314052","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.796104+00:00","generated_at":"2026-06-01T02:44:32.974058+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Anavex Life Sciences Announces Results of 2024 Annual Meeting of Stockholders","bullets":["Elected six directors including Christopher Missling, PhD, with 30,256,642 for and 3,637,351 against, plus 22,413,981 broker non-votes.","Ratified Grant Thornton LLP as independent auditor with 54,408,426 for, 1,275,036 against, and 624,512 abstentions.","Approved non-binding advisory resolution on executive compensation (say-on-pay) with 28,406,111 for, 4,728,255 against.","Shareholder proposal on golden parachutes failed with 18,454,499 against, 13,199,210 for, and 2,240,280 abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-24-001003","json":"https://secwatch.observer/filing/0001731122-24-001003.json","markdown":"https://secwatch.observer/filing/0001731122-24-001003.md","text":"https://secwatch.observer/filing/0001731122-24-001003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314052/000173112224001003/0001731122-24-001003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314052/000173112224001003/e5761_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:44:32.974058+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}